Student-centered Pipeline to Advance Research in Cancer Careers (SPARCC): Diversifying the Clinical Cancer Research Workforce

被引:1
|
作者
Kaljo, Kristina [1 ]
Ngui, Emmanuel M. [2 ]
Treat, Robert [3 ]
Rader, Janet S. [4 ]
机构
[1] Med Coll Wisconsin, Dept Obstet & Gynecol, 9200 West Wisconsin Ave, Milwaukee, WI 53202 USA
[2] Univ Wisconsin, Joseph J Zilber Sch Publ Hlth, Milwaukee, WI 53201 USA
[3] Med Coll Wisconsin, Off Acad Affairs, Milwaukee, WI 53226 USA
[4] Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA
关键词
Pipeline program; Underrepresented minority students; Clinical cancer research; INVESTIGATORS; RECRUITMENT; EDUCATION; TRIALS;
D O I
10.1007/s13187-021-02127-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A lack of diversity in the clinical cancer workforce causes undue burden limiting research and patient care advancements. Recruitment and retention of individuals underrepresented in medicine/research can enhance patient-provider concordance. The Student-centered Pipeline to Advance Research in Cancer Careers (SPARCC) uniquely prepares underrepresented minority students to quickly transition into the clinical research workforce and seek advanced graduate degrees. Experiential learning theory and culturally responsive pedagogy ground SPARCC's rigorous competency-based curriculum incorporating cancer care, clinical trial development, social supports, and mentored research experiences. Concurrent mixed-methods analysis includes evaluations of workshops, clinical-practicums, and pre-, post-, and 6-month-post-knowledge, attitudes, and practices. Analysis of data included stepwise multivariate regression analysis, Spearman's rho correlations, and assessments of inter-item reliability via Cronbach's alpha (IBM (R) SPSS (R) 24.0). Inductive content analysis coded phrases and analytic patterns were distilled enhancing descriptions of experiences. From January 2019 to March 2019, 62% of applications came from underrepresented minorities. Ten students were accepted, 90% identified as underrepresented minority. All ten students completed the pre-, post-, and 6-month-post-evaluations. Overall scores increased significantly from pre-evaluation to 6-month-post-evaluation. Evaluation data came from 431 responses of 60 workshops, with a mean score of 9.1 (10-point scale). Students completed three clinical practicums, which received an overall mean score of 8.2 (10-point scale). A robust curriculum, structured recruitment, diverse faculty, and comprehensive evaluations made SPARCC a compelling strategy for supporting underrepresented minority students to seek immediate employment as clinical research professionals or application to advanced graduate degree programs.
引用
收藏
页码:370 / 377
页数:8
相关论文
共 50 条
  • [41] Under-representation of Women in High-impact Published Clinical Cancer Research
    Jagsi, Reshma
    Motomura, Amy R.
    Amarnath, Sudha
    Jankovic, Aleksandra
    Sheets, Nathan
    Ubel, Peter A.
    CANCER, 2009, 115 (14) : 3293 - 3301
  • [42] Recent Developments in the Management of Cancer Pain in Japan: Education, Clinical Guidelines and Basic Research
    Yamaguchi, Takashi
    Narita, Minoru
    Morita, Tatsuya
    Kizawa, Yoshiyuki
    Matoba, Motohiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (12) : 1120 - 1127
  • [43] Developing a clinical and biological measures of aging core: Cancer and Aging Research Group infrastructure
    Koll, Thuy T.
    Magnuson, Allison
    Dale, William
    LaBarge, Mark A.
    Leach, Corinne R.
    Mohile, Supriya
    Muss, Hyman
    Sedenquist, Margaret
    Klepin, Heidi D.
    JOURNAL OF GERIATRIC ONCOLOGY, 2020, 11 (02) : 343 - 346
  • [44] Win Statistics in Observational Cancer Research: Integrating Clinical and Quality-of-Life Outcomes
    Chiaruttini, Maria Vittoria
    Lorenzoni, Giulia
    Spolverato, Gaya
    Gregori, Dario
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (11)
  • [45] Equitable Representation of Latinos in Clinical Research Is Needed to Achieve Health Equity in Cancer Care
    Ramirez, Amelie G.
    Chalela, Patricia
    JCO ONCOLOGY PRACTICE, 2022, 18 (05) : 402 - E804
  • [46] Nurse Practitioners' attitudes about cancer clinical trials and willingness to recommend research participation
    Ulrich, Connie M.
    Zhou, Quiping
    Ratcliffe, Sarah J.
    Ye, Lichuan
    Grady, Christine
    Watkins-Bruner, Deborah
    CONTEMPORARY CLINICAL TRIALS, 2012, 33 (01) : 76 - 84
  • [47] Recruitment challenges in clinical research: Survey of potential participants in a diagnostic study of ovarian cancer
    Sun, Zhuoyu
    Gilbert, Lucy
    Ciampi, Antonio
    Basso, Olga
    GYNECOLOGIC ONCOLOGY, 2017, 146 (03) : 470 - 476
  • [48] Profiling clinical cancer research across the Atlantic: A review of research and its characteristics presented at ASCO and ESMO Congresses during the last decade
    Pentheroudakis, George
    Krikelis, Dimitrios
    Cervantes, Andres
    Vermorken, Jan
    Pavlidis, Nicholas
    CANCER TREATMENT REVIEWS, 2012, 38 (06) : 560 - 565
  • [49] The European Organization for Research and Treatment for Cancer (EORTC) strategy for quality assurance in surgical clinical research: Assessment of the past and moving towards the future
    Tanis, E.
    Caballero, C.
    Collette, L.
    Verleye, L.
    den Dulk, M.
    Lacombe, D.
    Schuhmacher, C.
    Werutsky, G.
    EJSO, 2016, 42 (08): : 1115 - 1122
  • [50] Opening the Regulatory Black Box of Clinical Cancer Research: Transnational Expertise Networks and “Disruptive” Technologies
    Alberto Cambrosio
    Pascale Bourret
    Peter Keating
    Nicole Nelson
    Minerva, 2017, 55 : 161 - 185